Kidney Protection by a Novel Keap1-Nrf2 Protein-Protein Interaction Inhibitor for a Mouse Model of Alport Syndrome

被引：0

作者：

Horizono, Jun ^{[1
]}

Kaseda, Shota ^{[1
]}

Sannomiya, Yuya ^{[1
]}

Suico, Mary Ann ^{[1
]}

Fukiya, Hirohiko ^{[2
]}

Sunamoto, Hidetoshi ^{[2
]}

Watanabe, Hiroshi ^{[3
]}

Nakano, Takehiro ^{[3
]}

Tokumaru, Kai ^{[3
]}

Davenport, John Bernard

John, Bernard ^{[4
]}

Shuto, Tsuyoshi ^{[1
]}

Lennon, Rachel

Onuma, Kazuhiro ^{[2
]}

Kai, Hirofumi ^{[1
]}

机构：

[1] Kumamoto Univ, Grad Sch Pharmaceut Sci, Dept Mol Med, Kumamoto, Kumamoto, Japan

[2] UBE Corp, Pharmaceut Res Lab, Yamaguchi, Japan

[3] Kumamoto Univ, Grad Sch Pharmaceut Sci, Dept Biopharmaceut, Kumamoto, Japan

[4] Univ Manchester, Wellcome Ctr Cell Matrix Res, Manchester, Lancs, England

来源：

JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY | 2024年 / 35卷 / 10期

关键词：

D O I：

10.1681/ASN.2024x8p67yq0

中图分类号：

R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];

学科分类号：

1002 ; 100201 ;

摘要：

SA-PO640

引用

页数：2

共 50 条

[31] Novel Hydrogen Sulfide Hybrid Derivatives of Keap1-Nrf2 Protein-Protein Interaction Inhibitor Alleviate Inflammation and Oxidative Stress in Acute Experimental Colitis
Zhang, Xian
Cui, Keni
Wang, Xiaolu
Tong, Yuanyuan
Liu, Chihong
Zhu, Yuechao
You, Qidong
Jiang, Zhengyu
Guo, Xiaoke
ANTIOXIDANTS, 2023, 12 (05)
[32] Synthesis of Keap1-phosphorylated p62 and Keap1-Nrf2 protein-protein interaction inhibitors and their inhibitory activity
Yasuda, Daisuke
Nakajima, Mao
Yuasa, Akihiro
Obata, Rika
Takahashi, Kyoko
Ohe, Tomoyuki
Ichimura, Yoshinobu
Komatsu, Masaaki
Yamamoto, Masayuki
Imamura, Riyo
Kojima, Hirotatsu
Okabe, Takayoshi
Nagano, Tetsuo
Mashino, Tadahiko
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2016, 26 (24) : 5956 - 5959
[33] Small molecules inhibiting Keap1-Nrf2 protein-protein interactions: a novel approach to activate Nrf2 function
Zhuang, Chunlin
Wu, Zhongli
Xing, Chengguo
Miao, Zhenyuan
MEDCHEMCOMM, 2017, 8 (02) : 286 - 294
[34] Direct inhibition of Keap1-Nrf2 Protein-Protein interaction as a potential therapeutic strategy for Alzheimer's disease
Sun, Yi
Huang, Jiaxuan
Chen, Yufei
Shang, Hao
Zhang, Wannian
Yu, Jianqiang
He, Ling
Xing, Chengguo
Zhuang, Chunlin
BIOORGANIC CHEMISTRY, 2020, 103
[35] Fragment-growing guided design of Keap1-Nrf2 protein-protein interaction inhibitors for targeting myocarditis
Meng, Ning
Tang, Hua
Zhang, Hao
Jiang, Chengshi
Su, Li
Min, Xiao
Zhang, Wannian
Zhang, Hua
Miao, Zhenyuan
Zhang, Wen
Zhuang, Chunlin
FREE RADICAL BIOLOGY AND MEDICINE, 2018, 117 : 228 - 237
[36] Design of anti-depressant phosphodiester amino acidic Keap1-Nrf2 protein-protein interaction inhibitors
Sun, Yi
Wang, Jue
Ding, Wenxin
Qin, Qingqing
Wang, Rui
Yu, Ruizhi
Yan, Jianyu
Hou, Ruilin
Liu, Guodong
Cai, Xiangming
Qu, Zhuo
Zhang, Wannian
Yu, Jianqiang
Xing, Chengguo
Zhuang, Chunlin
REDOX BIOLOGY, 2025, 82
[37] Discovery of disubstituted xylylene derivatives as small molecule direct inhibitors of Keap1-Nrf2 protein-protein interaction
Abed, Dhulfiqar Ali
Lee, Sumi
Hu, Longqin
BIOORGANIC & MEDICINAL CHEMISTRY, 2020, 28 (06)
[38] Novel protein-protein interaction inhibitor of Nrf2-Keap1 discovered by structure-based virtual screening
Sun, Hao-Peng
Jiang, Zheng-Yu
Zhang, Ming-Ye
Lu, Meng-Chen
Yang, Ting-Ting
Pan, Yang
Huang, Hao-Ze
Zhang, Xiao-Jin
You, Qi-dong
MEDCHEMCOMM, 2014, 5 (01) : 93 - 98
[39] In silico approach of bioactive molecule chitosan 501.1 kDa from snail shell as antioxidant and inhibitor of the keap1-nrf2 protein-protein interaction
Umarudin, U.
Widyarti, Sri
Warsito, W.
Rahayu, Sri
PHARMACY EDUCATION, 2023, 23 (04): : 5 - 10
[40] Neuroprotective effect of a Keap1-Nrf2 Protein-Protein Inter-action inhibitor on cerebral Ischemia/Reperfusion injury
Qi, Zengxin
Tong, Yusheng
Luo, Hao
Chen, Ming
Zhou, Nan
Chen, Liang
BIOORGANIC CHEMISTRY, 2023, 132

← 1 2 3 4 5 →